866-997-4948(US-Canada Toll Free)

Global Molecular Diagnostics Market Report: 2013 Edition

Published By :

Koncept Analytics

Published Date : Jul 2013

Category :

Molecular Diagnostics

No. of Pages : 57 Pages

Human race has been persistently involved in a never ending pursuit for discovery and innovation in every field with a special inclination towards medical sciences. The perseverant efforts have triggered swift evolution in the realm of diagnostic tools and techniques. In-vitro diagnostic (IVD) tests are deployed for examining specimens including blood and tissues extracted from human body chiefly in order to detect the presence of concerning physiological/pathological state, or concerning congenital abnormality. Under the IVD market falls the ‘Molecular Diagnostics’ sector which involves performing analysis at the molecular level, and thereby measurement of DNA, RNA, proteins or metabolites to detect genotypes, mutations or biochemical changes, or to test for specific states of health or disease. Such diagnostic methods are capable of detecting viruses, bacteria, and parasites at a fast pace with greater sensitivity and specificity.

The molecular diagnostics procedures for infectious diseases including HPV, CT/NG; and the deadly gene linked cancer represent the largest market category in terms of revenue generation. Since the realm of cancer detection and screening procedures is undergoing a major change, the Oncology segment of the market is poised to undergo noteworthy expansion in the near future thereby driving the molecular diagnostics market on the holistic basis.

As of now, the global molecular diagnostics market is characterized by growth in large value mergers and acquisitions, personalized treatment in the field of Oncology and reimbursement trend. While the global molecular diagnostics marketplace remains marred by challenges like rising price pressures and growing regulatory hurdles; the underlying growth drivers including the ever increasing demand for better healthcare solutions, coupled with ageing world population, reimbursement, increasing insurance density, growing demand for genetic testing and rising new incidences of cancer, are taking the molecular diagnostics market to new heights.

The report analyzes the global molecular diagnostics market on a global scale and its various segments and also provides detailed information regarding the key umbrella markets including the diagnostics and IVD industry. It further discusses the various industry trends, growth drivers and challenges faced by the respective industry. In addition to the market contention prevalent in the global molecular diagnostics market, major industry players including Roche Holdings, Abbott Laboratories, Hologic and Novartis AG are profiled herein.

By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
Table of Content

1. Diagnostics: An Overview
1.1 In Vitro Diagnostics
1.2 Molecular Diagnostics

2. Diagnostics Market Structure
2.1 In Vitro Diagnostics (IVD) Market
  • Market Value
  • Market Segments
2.2 Global Molecular Diagnostics Market
  • Market Value
  • Market Segments
2.2.1 Molecular Diagnostics - Segment Analysis
a) HPV
  • Market Value
  • Penetration Rate
b) CT/NG
  • Market Value
2.2.2 Global Genetic Testing Market
  • Market Value

3. Market Dynamics
3.1 Industry Trends and Developments
3.1.1 Molecular Diagnostics in Oncology: Focus on Personalized Treatment
3.1.2 Growing M&A Activity in the Molecular Diagnostics Landscape
3.1.3 Reimbursement
3.1.4 Penetrating Point of Care Diagnostics
3.1.5 Emerging Korean Molecular Diagnostics Business
3.2 Growth Drivers
3.2.1 Increasing Prevalence of Cancer
3.2.2 Rising Demand for Better Healthcare Options
3.2.3 Diabetic Population
3.2.4 Growing Ageing Population (+60 Years) 
3.2.5 Ameliorating Economic Conditions
3.2.6 Increasing Insurance Density
3.2.7 Low Penetration of Vitamin D Tests
3.2.8 Growth in Genetic Testing Procedures
3.3 Challenges
3.3.1 Stringent Regulations
3.3.2 Mounting Price Pressure

4. Competitive Landscape
  • Competitive Overview
  • Market Share

5. Company Profiles
5.1 Hologic, Inc.
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies
  • Focus on Research & Development
  • Expansion via Strategic Acquisitions
5.2 Abbott Laboratories
5.2.1 Business Overview
5.2.2 Financial Highlights
5.2.3 Business Strategies
  • Mergers and Acquisitions
  • Expansion in Emerging Markets
5.3 Roche Holdings AG
5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategies
  • Focus on Innovative Diagnostics
  • Expertise in Molecular Biology
5.4 Novartis AG
5.4.1 Business Overview
5.4.2 Financial Overview
5.4.3 Business Strategies
  • Strong Product Pipeline
  • Leadership in Innovation

6. Market Outlook
6.1 Market Forecast
6.2 Forecast Methodology
6.2.1 Dependent and Independent Variables
6.2.2 Correlation Analysis
6.2.3 Regression Analysis

List of Table

Global HPV Market Model (2011-2015E) 
CT/NG Market Model (2011-2015E) 
Main M&A Deals in the Molecular Diagnostics Sector (2009-2012) 
Patients Worldwide Waiting for Better Treatment Options (2011) 
IVD Market Key Players-by Segments
Dependent & Independent Variables (2007-2012) 
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output

List of Chart

IVD Market – Segments by Technology
Molecular Diagnostcs – Traditional Process
Main Purposes of Molecular Diagnostics
Global Diagnostics Market (2005-2012E) 
Global IVD Market (2006-2011) 
IVD Market Share by Major Segments (2012) 
Global Molecular Diagnostics Market (2005-2012) 
Molecular Diagnostics Market Share by Segment
Infectious Disease Market Segmentation
HPV Testing Market Penetration Rates in the US (2010-2013E) 
Global Genetic Testing Market (2007-2011) 
Current Standards of Care in Various Therapeutic Areas (2011) 
Number of IVD M&A’s per Year (2009-2012) 
Number of M&A Deals According to Primary IVD Target Company Focus (2009-2012) 
Number of IVD Partnership Deals by Deal Type
Number of Cancer Cases Worldwide (2007-2011) 
World Population with Diabetes, Age Group 20-79 years (2006-2012) 
Global Ageing Population (2005-2013F) 
Global GDP (2001-2011) 
World GDP per Capita (2005-2011) 
Global Insurance Density (2004-2011) 
Global Vitamin D Market (2007-2011) 
Vitamin D Tests Penetration by Region (2011E) 
Number of Genetic Tests and Laboratories Available Worldwide (1993-2011) 
Worldwide Number of Diseases with Availability of Genetic Testing (2005-2011) 
Global IVD Market Share by Company (2012) 
Global Molecular Diagnostics Market Share by Company (2012) 
Global CT/GC Market Share by Leading Companies (2011) 
Hologic’s Revenue Share by Business Segment (2012) 
Hologic’s Revenues and Net Income (2008-2012) 
Abbott Laboratories Revenue – Share by Segments (2012) 
Abbott Laboratories Revenue (2008-2012) 
Roche’s Revenues by Business Segments (2012) 
Roche’s Revenues and Net Income (2008-2012) 
Novartis’ Revenue Share by Business Segments (2012) 
Novartis’ Revenues and Net Income (2008-2012) 
Global Molecular Diagnostics Market Forecast (2010-2015F)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *